Shin-Ichiro Imai

Title: The Innovative Contributions of Shin-Ichiro Imai

Introduction

Shin-Ichiro Imai is a prominent inventor based in St. Louis, MO (US). He has made significant contributions to the field of medical research, particularly in the treatment of age-associated conditions. With a total of 9 patents, Imai's work focuses on the therapeutic potential of nicotinamide mononucleotide (NMN).

Latest Patents

Imai's latest patents include compositions and methods of treatment using nicotinamide mononucleotide. These patents describe various methods and compositions for treating age-associated conditions and other medical issues, such as muscle diseases, type 2 diabetes, and obesity. His work outlines methods for enhancing cellular uptake of NMN and stimulating NAD+ production. Additionally, he has disclosed gene therapy vectors comprising a nucleic acid encoding the Slc12a8 protein, as well as methods for screening candidate compounds that promote NMN transport. Another significant aspect of his research involves the administration of NMN in treating diseases, including age-related obesity and cognitive decline.

Career Highlights

Throughout his career, Imai has worked with prestigious institutions such as Washington University and the Massachusetts Institute of Technology. His research has garnered attention for its innovative approach to addressing age-related health issues.

Collaborations

Imai has collaborated with notable researchers, including Leonard P. Guarente and Javier R. Revollo. These partnerships have further advanced the understanding of NMN and its potential applications in medicine.

Conclusion

Shin-Ichiro Imai's contributions to the field of medical research through his innovative patents and collaborations highlight the importance of continued exploration in the treatment of age-associated conditions. His work promises to pave the way for new therapeutic strategies that could significantly improve health outcomes.